Evonile Pharma Limited (NOVARTIND.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In INR
Address
Inspire BKC, G Block
Mumbai, MH 400051
India
Phone
91 22 5024 3000
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
59
First IPO Date
October 07, 2020
| Name | Title | Pay | Year Born |
| Vasant Narasimhan | Chief Executive Officer of Novartis | 0 | 1976 |
| Vikas Gupta | Executive Director, MD & CEO | 0 | 1976 |
| Shilpa Joshi | Chief Financial Officer & Whole-Time Director | 11.17M | 1969 |
| Bhagwat Singh Deora | Chief Financial Officer | 0 | 1982 |
| Gagan Sharma | President Specialty Business | 0 | N/A |
| Chandni Maru | Company Secretary & Compliance Officer | 0 | N/A |
Evonile Pharma Limited, an affiliate of Novartis AG, operates as a healthcare enterprise primarily within India. The company's diverse portfolio encompasses a range of therapeutic solutions. These include bone and pain management treatments sold under the Voveran brand, an array of transplantation immunology medications such as Simulect, Certican, Sandimmun, Neoral, and Myfortic, and neuroscience products like Tegrital and Exelon. Founded in 1947, its principal operations are based in Mumbai, India.